# Blue Jet Healthcare Ltd (BLUEJET)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹481.4
Day Change: +9.15%
52W High: ₹1027.8
52W Low: ₹325
Market Cap: ₹7,304 Cr

## Valuation
P/E: 24.9
P/B: 5.81
EPS: ₹16.91
Book Value: ₹72.5
Dividend Yield: 0%

## Returns
1Y Return: -23.46%

## Profitability
ROE: 0%
ROCE: 32.13%
Debt/Equity: 0.02
Revenue Growth: -39.6%
Profit Growth: -59.4%
EBITDA Margin: 33.1%
Operating Margin: 21.26%

## About
Blue Jet Healthcare Ltd is a Biotechnology company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Biotechnology
Sub Industry: Unknown

## Business Model
Overview: Blue Jet Healthcare Ltd makes money through Technology services, Digital transformation projects, Maintenance and managed services in Biotechnology. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Technology services
- Digital transformation projects
- Maintenance and managed services
Operating Model:
- Wins client contracts, deploys skilled delivery teams, and earns project or recurring service revenue.
- Utilisation, billing rates, attrition, and currency movements are key operating levers.
Recent Context:
- Announcement: Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Announcement: Closure of Trading Window
- BSE Filing: Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

## Data Freshness
Quote Updated: 2026-05-25T18:00:11.510Z
Price History Updated: 2026-05-25T05:26:22.817Z
Latest Price History Date: 2026-05-24
Technicals Updated: 2026-05-25T05:26:22.817Z
Quant Updated: 2026-05-25T05:26:22.817Z
Sentiment Updated: 2026-05-25T05:26:22.817Z
Financials Status: current
Financials Updated: 2026-05-18T11:32:08.911Z
Financials Last Attempt: 2026-05-18T11:32:08.911Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2021)
Revenue: ₹538 Cr
Operating Profit: ₹214 Cr (OPM 40%)
Net Profit: ₹145 Cr
Tax: ₹194 Cr

## Balance Sheet (Mar 2021)
Total Assets: ₹375 Cr
Total Liabilities: ₹375 Cr
Borrowings: ₹79 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Akshay Bansarilal Arora, Executive Chairman
- Shiven Akshay Arora, MD & Director
- Naresh Suryakant Shah, Executive Director
- Popat Bhagwan Kedar, Whole-Time Director
- Ganesh  Karuppannan, Chief Financial Officer

---
Source: rupiya.io/stocks/bluejet
Disclaimer: For research and education only. Not investment advice.